Aureate Tradde IPO
Market Sentiment
IPO Details
IPO Reservation
Market Lot Size
Financial Analysis
| Metric | 2023 | 2024 | 2025 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 211.60 | 172.19 | 176.62 | 102.79 |
| Expense | 210.05 | 170.16 | 173.16 | 96.92 |
| Profit (PAT) | 1.13 | 1.45 | 2.57 | 4.36 |
| Total Assets | 38.71 | 64.18 | 83.11 | 98.58 |
Promoters: Mr. Kalash Kevin Shah and Mr. Punit Devendrabhai Shah
| Shareholding | No. of Shares | Holding % |
|---|---|---|
| Promoter Holding Pre Issue | 90,87,736 | 92.35% |
| Promoter Holding Post Issue | 1,29,85,736 | 64.63% |
Strengths & Risks
- Strong return on equity — 22%.
- Thin profit margin — 1.5%.
- Elevated leverage — debt/equity of 2.49.
Auto-generated from live GMP, subscription, valuation and financial data. Informational only — not investment advice. Always read the RHP before applying.
Company Information
Incorporated in 2018, Aureate Tradde Ltd. is engaged in the trading, distribution, and supply of industrial and technological materials in the domestic market. The company operates across three key business verticals: (i) polymers and petrochemicals, (ii) lithium-ion and sodium-ion cells, and (iii) electric vehicle chargers. The product portfolio includes PVC resins, PET resins, polyethylene (LDPE and HDPE grades), lithium-ion and sodium-ion cells, lithium and lead-acid chargers, and electric vehicle chargers. Operations are conducted under an inventory-based business model, wherein products are procured and stocked in advance to service customers across small, medium, and large enterprises. The company primarily operates in the domestic B2B segment for polymers, petrochemicals, lithium-ion cells, and sodium-ion cells, and in both B2B and B2C segments for electric vehicle chargers.
| Purpose | Amount (Cr) |
|---|---|
| Funding working capital requirements of the Company | 10.00 |
| Repayment/pre-payment, in full or in part, of certain borrowings availed by the Company | 9.93 |
| To meet out the General Corporate Purposes. | 4.09 |
Resources & Documents
Aureate Tradde Ltd., 404, Floor 4, Plot No. 208,, Regent Chambers, Jamnalal Bajaj Marg,, Nariman Point,, Mumbai, Maharashtra, 400021
Aureate Tradde has fixed the issue price at Rs 70 per share for an issue size of Rs 27 crore. The stock listed flat against its issue price.
Incorporated in 2018, Aureate Tradde Ltd. is engaged in the trading, distribution, and supply of industrial and technological materials in the domestic market.
The issue is promoted by Mr. Kalash Kevin Shah and Mr. Punit Devendrabhai Shah with Corporate Makers Capital Ltd. acting as lead manager. Net proceeds will primarily be used towards Funding working capital requirements of the Company (Rs 10 crore) and Repayment/pre-payment, in full or in part, of certain borrowings availed by the Company (Rs 10 crore).
Grey market is quoting a premium of +Rs 1 (+1.4% over issue price), down Rs 8 from the previous session. Final subscription data records overall subscription at 1.48x, retail at 2.42x, NII at 0.55x.
At the upper end of the price band, the issue is priced at a post-issue P/E of 24.73x. On fundamentals, the company is posting revenue growth of 2.6%, a profit margin of 1.5%, return on equity of 21.9% in its most recent reported period. Listed peers in this segment include Bhavik Enterprises Limited (P/E 43.85x) — useful reference points when evaluating the issue's pricing relative to where the broader sector is trading.
Our data-driven engine currently flags this issue as a Neutral stance — the data is mixed and the risk-reward is balanced rather than one-sided. Past performance does not predict future returns — review the price chart and peer comparison below before trading.
Understanding Grey Market Premium (GMP)
The Grey Market Premium (GMP) is an unofficial indicator of how an IPO's shares are trading in the grey market before they are officially listed on a stock exchange. It reflects investor sentiment and demand for the IPO shares ahead of listing day.
How does it work? The grey market is an informal, over-the-counter market where investors buy and sell IPO shares before the official listing date. If an IPO has a positive GMP, it suggests that investors expect the stock to list above its issue price. A negative GMP indicates expectations of a listing below the issue price.
Example: If an IPO has an issue price of ₹100 and the GMP is ₹50, the expected listing price would be approximately ₹150 (issue price + GMP). This translates to an estimated listing gain of 50%.
Factors that influence GMP:
- Subscription levels — Higher subscription typically drives GMP up
- Market conditions — Bullish markets tend to boost GMP across all IPOs
- Company fundamentals — Strong financials and growth potential attract premium
- Industry sentiment — Positive outlook for the sector can increase demand
- IPO pricing — Reasonably priced IPOs relative to peers tend to command higher GMP
Disclaimer: GMP is an unofficial metric from the grey market and is not regulated by SEBI or any stock exchange. GMP values fluctuate frequently and should not be the sole basis for investment decisions. Always consider company fundamentals, financial health, and your own risk appetite before investing in any IPO.
Related IPO
No comments yet. Be the first to share your opinion!